суббота, 20 ноября 2010 г.

Synthesis of tert-butyl (1H-benzo[d]imidazol-2-yl)methylcarbamate.





tert-Butyl (1H-benzo[d]imidazol-2-yl)methylcarbamate.
Benzene-1, 2-diamine (1.05 g, 9.72 mmol) and N-(tert-butoxycarbonyl)glycine (1.71 g, 9.72 mmol) were dissolved in 30 ml of THF and cooled to 0 °C. Into the above solution was added N, N'-dicyclohexylcarbodiimide (2.41 g, 11.7 mmol ) in batches and the mixture was stirred at 0 °C for half an hour and then at room temperature overnight. The reaction mixture was filtrated and evaporated to afford a brown oil, which was purified by a silica-gel column chromatography (dichloromethane / methanol, 25:1 by volume) to get a yellow solid (2.24 g). The solid was dissolved in 20 ml of acetic acid and the solution was stirred at 72 °C for 8 h. The acetic acid was removed under reduced pressure and the crude compound was purified by a silica-gel column chromatography (dichloromethane / methanol, 25:1 by volume) to afford a white solid. Yield: 82%. m.p. 181-183 °C. IR (KBr) cm-1: 3343 (-NH-), 3058, 2980, 2940 (CH, aliphatic), 1686 (>C=O), 1529 (-C=C-), 736 (-Ar-); 1H NMR (300 MHz, CDCl3, δ ppm): 1.45 (s, 9H, CH3), 4.53-4.55 (d, 2H, J = 6.3 Hz, CH2), 6.12 (brs, 1H, NH), 7.22-7.25 (m, 2H, Ar-H), 7.54-7.60 (m, 2H, Ar-H); HRMS (ESI): [M + H]+ calcd m/z 248.1400, found 248.1397.δ ppm): 1.45 (s, 9H, CH3), 4.53-4.55 (d, 2H, J = 6.3 Hz, CH2), 6.12 (brs, 1H, NH), 7.22-7.25 (m, 2H, Ar-H), 7.54-7.60 (m, 2H, Ar-H); HRMS (ESI): [M + H]+ calcd m/z 248.1400, found 248.1397.

Комментариев нет:

Отправить комментарий

Ярлыки

AB1010 (1) ABT-869 (1) AG-013736 (1) ALK-kinase (1) AMG-706 (1) AP24534 (1) AV-951 (1) AZD-0530 (1) AZD2171 (2) Afatinib (2) Apatinib (1) Armala (1) BAY 73-4506 (1) BIBW 2992 (1) BMS-540215 (2) Bafenitib (1) Bafetinib (2) Brivanib (2) CEP-701 (1) CHIR258 (1) CP690550 (1) Cediranib (2) Crizotinib (1) Dasatinib (2) Dovitinib (1) Erlotinib (1) Foretinib (1) Gefinitib (1) Gefitinib (2) Gold reagent (1) HKI 272 (1) INNO-406 (2) Icotinib (1) Iressa (1) MLN 518 (1) Masitinib (1) Mubritinib (2) NS-187 (2) Nexavar (2) OSI-774 (1) PF-02341066 (1) PHA-739358 (1) Palladia (1) Pazopanib (2) Pelitinib (1) Ponatinib (1) Recentin (2) Regorafenib (1) Ruxolitinib (1) SKI-606 (2) Saracatinib (2) Silimitasertib (1) Sorafenib (2) Sorafenib tosylate (1) Sprycel (2) Sunitinib (2) Sunitinib Malate (2) Sutent (2) TKI-258 (1) Tarceva (2) Tasocitinib (1) Tivozanib (1) Tovok (2) Vatalanib (1) Votrient (2) YN968D1 (1) ZD6474 (1) axinitib (1) bosutinib (2) canertinib (1) danusertib (1) gleevec (1) imatinib (1) lapatinib (2) lestaurtinib (1) linifanib (1) nilotinib (1) pyrazole (1) sc-202353 (1) targeted agents (1) tasigna (1) toceranib (1) tykerb (2) tyverb (1) vandetanib (1) zactima (1) Бринатиниб (1) Гефитиниб (1) Кризотиниб (1) Маситиниб (1) Сунитиниб (2) Тарцева (2) Цедираниб (1) Эрлотиниб (2) акситиниб (1) ваталаниб (1) гливек (1) дазатиниб (2) данусертиб (1) зактима (1) икотиниб (1) карнетиниб (1) куизартиниб (1) лапатиниб (1) лекарства (1) лекарство (1) линифаниб (1) нексавар (1) понатиниб (1) руксолитиниб (1) сорафениб (1) спрайсел (2) сутент (1) тайверб (1) тандуниб (1) 凡德他尼 (1) 尼罗替尼 (1) 阿西替尼 (1)